文献速递甲状腺与颈部外科

近红外自体荧光辅助甲状旁腺识别降低甲状腺全切除术后低钙血症:PARAFLUO多中心随机临床试验

Association of Autofluorescence-Based Detection of the Parathyroid Glands During Total Thyroidectomy With Postoperative Hypocalcemia Risk: Results of the PARAFLUO Multicenter Randomized Clinical Trial.
PubMed 文献 · JAMA Surg · 2020-01-01

PARAFLUO多中心随机临床试验在法国3家转诊医院纳入245例成人甲状腺全切除术患者,比较术中近红外自体荧光(NIRAF)成像识别甲状旁腺与常规手术。NIRAF组暂时性术后低钙血症发生率为9.1%,对照组为21.7%,组间差异12.6%(95%CI 5.0%-20.1%;P=.007),永久性低钙血症无显著差异,NIRAF组甲状旁腺自体移植和误切率均更低。

要点

  • NIRAF辅助甲状腺全切除术可显著降低暂时性术后低钙血症发生率。
  • NIRAF组甲状旁腺自体移植率和误切率均显著低于常规手术组。
  • 永久性低钙血症发生率两组无显著差异。

核心结论

  • 术中NIRAF识别甲状旁腺可能显著改善甲状腺全切除术后早期低钙血症发生率并提高甲状旁腺保留。

研究设计与样本

  • 529例符合条件患者中245例随机分组,241例纳入主要结局分析:NIRAF组121例,常规手术对照组120例。
  • 纳入成人甲状腺全切除术患者,排除既存甲状旁腺疾病者。

主要发现

  • 暂时性术后低钙血症发生率NIRAF组9.1%(11/121),对照组21.7%(26/120),组间差异12.6%(95%CI 5.0%-20.1%;P=.007)。
  • 永久性低钙血症发生率NIRAF组0%,对照组1.6%(2/120),无显著差异。
  • 多因素分析校正中心和术者异质性及混杂因素后,NIRAF降低低钙血症风险的OR为0.35(95%CI 0.15-0.83;P=.02)。
  • 甲状旁腺自体移植率NIRAF组3.3%(4例;95%CI 0.1%-6.6%),对照组13.3%(16例;95%CI 7.3%-19.4%),P=.009。
  • 甲状旁腺误切率NIRAF组2.5%(3例;95%CI 0.0%-5.2%),对照组11.7%(14例;95%CI 5.9%-17.4%),P=.006。

关键数值与推荐

  • 主要结局为术后第1或2天校正钙<8.0 mg/dL(换算mmol/L乘以0.25)的术后低钙血症发生率。

临床怎么用

  • 甲状腺全切除术中可考虑使用NIRAF成像系统辅助识别甲状旁腺,以降低暂时性术后低钙血症和甲状旁腺误切风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Because inadvertent damage of parathyroid glands can lead to postoperative hypocalcemia, their identification and preservation, which can be challenging, are pivotal during total thyroidectomy. OBJECTIVE: To determine if intraoperative imaging systems using near-infrared autofluorescence (NIRAF) light to identify parathyroid glands could improve parathyroid preservation and reduce postoperative hypocalcemia. DESIGN, SETTING, AND PARTICIPANTS: This randomized clinical trial was conducted from September 2016 to October 2018, with a 6-month follow-up at 3 referral hospitals in France. Adult patients who met eligibility criteria and underwent total thyroidectomy were randomized. The exclusion criteria were preexisting parathyroid diseases. INTERVENTIONS: Use of intraoperative NIRAF imaging system during total thyroidectomy. MAIN OUTCOMES AND MEASURES: The primary outcome was the rate of postoperative hypocalcemia (a corrected calcium <8.0 mg/dL [to convert to mmol/L, multiply by 0.25] at postoperative day 1 or 2). The main secondary outcomes were the rates of parathyroid gland autotransplantation and inadvertent parathyroid gland resection. RESULTS: A total of 245 of 529 eligible patients underwent randomization. Overall, 241 patients were analyzed for the primary outcome (mean [SD] age, 53.6 [13.6] years; 191 women [79.3%]): 121 who underwent NIRAF-assisted thyroidectomy and 120 who underwent conventional thyroidectomy (control group). The temporary postoperative hypocalcemia rate was 9.1% (11 of 121 patients) in the NIRAF group and 21.7% (26 of 120 patients) in the control group (between-group difference, 12.6% [95% CI, 5.0%-20.1%]; P = .007). There was no significant difference in permanent hypocalcemia rates (0% in the NIRAF group and 1.6% [2 of 120 patients] in the control group). Multivariate analyses accounting for center and surgeon heterogeneity and adjusting for confounders, found that use of NIRAF reduced the risk of hypocalcemia with an odds ratio of 0.35 (95% CI, 0.15-0.83; P = .02). Analysis of secondary outcomes showed that fewer patients experienced parathyroid autotransplantation in the NIRAF group than in the control group: respectively, 4 patients (3.3% [95% CI, 0.1%-6.6%) vs 16 patients (13.3% [95% CI, 7.3%-19.4%]; P = .009). The number of inadvertently resected parathyroid glands was significantly lower in the NIRAF group than in the control group: 3 patients (2.5% [95% CI, 0.0%-5.2%]) vs 14 patients (11.7% [95% CI, 5.9%-17.4%], respectively; P = .006). CONCLUSIONS AND RELEVANCE: The use of NIRAF for the identification of the parathyroid glands may help improve the early postoperative hypocalcemia rate significantly and increase parathyroid preservation after total thyroidectomy. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02892253.

来源:JAMA Surg,查看原文。版权归原作者所有。

引用

  1. Benmiloud F, Godiris-Petit G, Gras R, et al. Association of Autofluorescence-Based Detection of the Parathyroid Glands During Total Thyroidectomy With Postoperative Hypocalcemia Risk: Results of the PARAFLUO Multicenter Randomized Clinical Trial. JAMA Surg. 2020. PMID: 31693081. doi:10.1001/jamasurg.2019.4613

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。